Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder.

Baba C., Kaya E., Ozcelik S., Ozdogar A. T., Samedzade U., Cevik S., et al.
Clinical neurology and neurosurgery , cilt.238, sa.238, ss.108152, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

Relationship between presence of spinal cord lesion and restless legs syndrome in multiple sclerosis

Baba C., Ozdogar A. T., ÖZÇELİK S., KAYA E., ÖZAKBAŞ S.
SOMATOSENSORY AND MOTOR RESEARCH , sa.2-4, ss.116-120, 2022 (SCI-Expanded) identifier identifier

Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies.

Baba C., Ozcelik S., Kaya E., Samedzada U., Ozdogar A. T., Cevik S., et al.
Multiple sclerosis and related disorders , cilt.68, ss.104119, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies

Özakbaş S., Baba C., Doğan Y., Cevik S., Özçelik S., Kaya E.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.58, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

Relationship Between Upper Extremity Functions and Gait in People with Multiple Sclerosis

Daştan S., Özçelik S., Yavaş İ., Özdoğar A. T.
Journal of Multiple Sclerosis Research , cilt.2, sa.2, ss.41-45, 2022 (Hakemli Dergi) Creative Commons License

Awareness and Knowledge Levels of Osteoporosis in Patients with Multiple Sclerosis

Karakaş A., Erdinç Gündüz N., Özçelik S., Limoncu H., Dilek B., Gülbahar S., et al.
TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS , cilt.28, sa.2, ss.131-136, 2022 (ESCI)

The Efficacy of Fampridine on Upper Extremity Functions in Individuals with Multiple Sclerosis: Is There a Difference between Cerebellar and Pyramidal Dysfunction?

Ozdogar A. T., Ozcelik S., Dastan S.
Journal of Multiple Sclerosis Research , cilt.1, sa.1, ss.75-78, 2021 (Hakemli Dergi) Creative Commons License

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Asymmetrical Neuroimaging Insights in CSF-Validated Early-Onset Alzheimer's: Integrating PET, MRI, and Cognitive Assessment

Özçelik S., Yiğit P., Bozdemir T. C., Çapa Kaya G., Yıldırım Z., Tee B. L., et al.
the Alzheimer’s Association International Conference, Pennsylvania, Amerika Birleşik Devletleri, 28 Temmuz - 01 Ağustos 2024

Correlation of Clinical and Imaging Findings in Early-Onset Alzheimer's Patients with Distinct Initial Symptoms

Özçelik S., Yiğit P., Bozdemir T. C., Çapa Kaya G., Yıldırım Z., Tee B. L., et al.
Alzheimer's Association International Conference, Pennsylvania, Amerika Birleşik Devletleri, 28 Temmuz - 01 Ağustos 2024

Effects of two grams of methylprednisolone in people with multiple sclerosis who received one gram of methylprednisolone for relapses

Alızada S., Özçelik S., Dastan S., Sagici O., Özdoğar A. T., Ozakbas S.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.1040 Creative Commons License identifier

Serum progranulin levels and cognitive function in people with multiple sclerosis: limited evidence for an association

KAYA E., Cevik S., Sagici O., ÖZÇELİK S., DOĞAN Y., Ozakbas S.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.902-903 identifier

A comparison of cognitive batteries to assess cognitive impairment in multiple sclerosis

Yiğit P., Sağıcı Ö., Özçelik S., Abasıyanık Z., Kaya E., Baba C., et al.
The 9th Joint ECTRIMS-ACTRIMS Meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.102

Efficacy of Original Fingolimod vs. Generic-Brand Drugs in Treating Multiple Sclerosis: A comparative Study Using Real-World Data from Turkey

Özçelik S., Sağıcı Ö., Özdoğar A. T., Kaya E., Özakbaş S.
The 9th Joint ECTRIMS-ACTRIMS Meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.292-293

Physical and cognitive profile of elderly persons with multiple sclerosis and comparison with healthy controls

Özakbaş S., Özdoğar A. T., Baba C., Özçelik S., Kaya E., Sağıcı Ö.
ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.821, ss.705 Creative Commons License

Effects of ocrelizumab on disability progression and inflammatory activity in multiple sclerosis patients during the two-year follow-up

Özakbaş S., Baba C., Kaya E., Özçelik S., Özdoğar A. T., Daştan S.
ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.1084, ss.862 Creative Commons License

Cognitive profile of persons with newly diagnosed multiple sclerosis

Özakbaş S., Sağıcı Ö., Özçelik S., Karakaş H., Baba C.
ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.359, ss.431 Creative Commons License

Correlation of optic coherence tomography and angiography with cognitive functions in multiple sclerosis

Baba C., Özçelik S., Özizmirliler D., Güney F., Sağıcı Ö., Yaman A., et al.
ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.646, ss.578 Creative Commons License

Real-world data of ocrelizumab effects on disability progression; A 2-year follow-up study

Baba C., Kaya E., Özçelik S., Özdoğar A. T., Sağıcı Ö., Daştan S., et al.
ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.821, ss.860 Creative Commons License

Cognitive functions in persons with multiple sclerosis treated with fingolimod: 2-years follow-up study

Özakbaş S., Yiğit P., Baba C., Kaya E., Sağıcı Ö., Özçelik S., et al.
ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.359, ss.378 Creative Commons License

COVID-19 antibody response after two doses of SARS-CoV-2 vaccines in multiple sclerosis patients; an update to the previous study

Ozakbas S., Baba C., ÖZÇELİK S., Özdoğar A. T., KAYA E., DOĞAN Y., et al.
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, sa.922, ss.764-765 Creative Commons License Sürdürülebilir Kalkınma identifier

Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients

Ozakbas S., Baba C., SAMADZADE U., KAYA E., ÖZÇELİK S., Özdoğar A. T., et al.
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, sa.941, ss.776 Creative Commons License identifier

Pregabalin ile tedavi edilen huzursuz genital sendrom olgusu

Yaka E. C., ÖZÇELİK S., ŞENGÜN İ. Ş., YAKA E.
3. Uluslararası ve 7.İlaç ve Tedavi Kongresi, Bafra, Kıbrıs (Kktc), 21 Eylül 2022

AKUT DİSSEMİNE ENSEFALOMİYELİT (ADEM) Mİ ? MULTİPLE SKLEROZ (MS) İLK EPİZODU MU ? OLGU SUNUMU EŞLİĞİNDE GÖZDEN GEÇİRME;

AYGÜNDÜZ YAPICI N., ÖZÇELİK S., ÖZAKBAŞ S.
57. Ulusal Nöroloji Kongresi, İzmir, Türkiye, 27 Kasım 2021

NADİR GÖRÜLEN ENSEFALİT SEBEPLERİNDEN CREUTZFELDT-JAKOB VE PARANEOPLASTİK ENSEFALOPATİ BİRLİKTELİĞİ

ÖZÇELİK S., AYGÜNDÜZ YAPICI N., ÇOBAN F. Y., ÖZBEK Y., ÖZ D.
57.ULUSAL NÖROLOJİ KONGRESİ, 27 Kasım 2021

Early treatment response of ocrelizumab in persons with multiple sclerosis: six-month results

Özakbaş S., Özçelik S., Kaya E., Özdoğar A. T., Sağıcı Ö., Baba C.
ECTRIMS, Vienna, Avusturya, 13 - 15 Kasım 2021, ss.278

Relationship between presence of spinal cord lesion and restless legs syndrome in multiple sclerosis

Özakbaş S., Özdoğar A. T., Baba C., Özçelik S., Kaya E.
ECTRIMS, Vienna, Avusturya, 13 - 15 Kasım 2021, ss.259

Comparison of early treatment response of ocrelizumab in relapsing and progressive multiple sclerosis patients on the basis of cognitive functions

Özakbaş S., Özçelik S., Kaya E., Özdoğar A. T., Sağıcı Ö., Baba C.
ECTRIMS, Vienna, Avusturya, 13 - 15 Kasım 2021, ss.276

SLE Tanısı ve Santral Sinir Sistemi Vaskülitik Tutulumu Olan Hastada Progresif İnme

ÖZÇELİK S., ÖZ D., KUTLUK M. K.
55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 15 - 21 Kasım 2019, ss.193

Metrikler

Yayın

28

Atıf (WoS)

23

H-İndeks (WoS)

2

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları